Endocrinology

Endocrinology is a branch of medicine dealing with disorder of the endocrine system and its specific secretions called hormones.

What is Endocrinology?

Clinical endocrinology is a branch of Medicine that deals with the endocrine glands, actions of hormones and their metabolic consequences.

How the Endocrine System Works

What are Enteroendocrine Cells?

What are Endocrine Disrupting Chemicals?

Does the Microbiome Interact with the Human Endocrine System?

Testing for Hormone-like Effects of Chemicals

Latest Endocrinology News and Research

Uncertainty surrounds effects of puberty blockers and hormone therapy for gender dysphoria

Major uncertainties remain about the impact of puberty blockers and gender affirming hormone therapy on children and young people with gender related distress (gender dysphoria), making it impossible to determine conclusively whether they help or harm, find two pooled data analyses of the available evidence, published online in the Archives of Disease in Childhood.

23 Jan 2025

New technique identifies SARS-CoV-2 in blood and other fluids with high sensitivity

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections, creating the potential for guiding future treatment of patients.

22 Jan 2025

Study highlights gaps in CVD risk models for people with HIV

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV (PWH).

20 Jan 2025

The Christie launches unique training program for cancer care doctors

A unique training programme for a new breed of cancer care doctors is underway at The Christie in Manchester, an international center of excellence in cancer care.

15 Jan 2025

Global Commission proposes new framework for obesity diagnosis and treatment

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organizations around the world, presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level.

15 Jan 2025

AI analysis reveals optimal follicle sizes for IVF success

During IVF treatment, doctors use ultrasound scans to monitor the size of follicles - small sacs in the ovaries containing eggs - to decide when to give a hormone injection known as the 'trigger' to prepare the eggs for collection and ensure that they are ready to be fertilised with sperm to create embryos.

8 Jan 2025

AI-based tool identifies subtypes of Type 2 diabetes using glucose monitors

Diabetes has long been lumped into two categories - Type 1, which often appears in childhood, or Type 2, which is associated with obesity and typically develops later in life. But scientists have learned that not all patients with Type 2 diabetes are the same, with some patients varying in body weight, age of onset and other characteristics.

7 Jan 2025

Fracture Liaison Services crucial for addressing global osteoporosis challenges

A new Perspective article published in the New England Journal of Medicine emphasizes the critical role of Fracture Liaison Services (FLS) in addressing the growing global burden of osteoporosis-related fractures, particularly hip fractures.

6 Jan 2025

European Society of Endocrinology announces first-ever World Hormone Day in 2025

After three successful years of raising awareness of the importance of good hormone health through European Hormone Day, the European Society of Endocrinology (ESE) and the European Hormone and Metabolism Foundation (ESE Foundation), have announced the first-ever World Hormone Day to take place on 24 April 2025.

24 Dec 2024

Study reveals tumor and immune cell interactions in craniopharyngiomas

Craniopharyngiomas are brain tumors that negatively impact the hormonal function of the nearby pituitary.

16 Dec 2024

Toxic chemical exposure in early life linked to behavioral problems in rats

Early life exposure to a class of endocrine-disrupting chemicals (EDCs) called polychlorinated biphenyls (PCBs) may lead to behavioral problems in rats, according to a new animal study published in the Journal of the Endocrine Society.

10 Dec 2024

Researchers develop diabetes prediction system using clinical and genetic data

A research team led by professor Nan-Hee Kim from Korea University's College of Medicine (Nan-Hee Kim and So-Young Park of Department of Endocrinology and Metabolism; Min-Hee Kim and Jae-Young Kim of Health Science Research Center) recently developed a diabetes prediction system using clinical and genetic data. The system was registered for the domestic patent.

5 Dec 2024

Women with premature ovarian insufficiency face higher risk of autoimmune diseases

Research reveals a significant association between premature ovarian insufficiency and autoimmune diseases, highlighting hypothyroidism as a common condition.

2 Dec 2024

Warmer temperatures weaken immune systems in wild capuchin monkeys

The immune performance of wild capuchin monkeys declines when the animals experience higher temperatures, and younger monkeys seem to be particularly vulnerable to heat, according to a University of Michigan study.

29 Nov 2024

Expert explores the expanding applications of GLP1 therapies

Researchers review recent advancements in glucagon-like peptide-1-based therapies.

28 Nov 2024

GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.

27 Nov 2024

First U.S. trial uses non-viral CRISPR to correct sickle cell mutation

UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease.

26 Nov 2024

Tirzepatide cuts diabetes risk by 90% in obese patients, study shows

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions.

26 Nov 2024

GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.

25 Nov 2024

Study finds bone density loss associated with levothyroxine

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone loss, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).

25 Nov 2024